Enzolytics, Inc. (OTCMKTS:ENZC) Sees Large Decline in Short Interest

Enzolytics, Inc. (OTCMKTS:ENZC) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 200 shares, a drop of 99.7% from the December 31st total of 57,300 shares. Based on an average daily volume of 7,205,900 shares, the short-interest ratio is presently 0.0 days.

Enzolytics Price Performance

Shares of OTCMKTS ENZC traded up $0.00 during mid-day trading on Thursday, hitting $0.00. 9,408,679 shares of the stock traded hands, compared to its average volume of 5,436,554. Enzolytics has a twelve month low of $0.00 and a twelve month high of $0.02.

Enzolytics Company Profile

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.